프로그램

Time Title Chairperson/Speaker
08:55-09:00 Registration
09:00-09:05 Opening Remarks Yun Sil Chang
(Director of Cell and Gene Therapy Institute, Samsung Medical Center, Korea)
09:05-09:10 Welcome Address Kyu-Sung Lee
(Director, Research Institute for Future Medicine, Samsung Medical Center, Korea)
09:10-09:15 Congratulatory Address Seung Woo park
(President of Samsung Medical Center, Korea)
Session I. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases Chair : Il-Hoan Oh
(The Catholic University of Korea, Korea)
Yun Sil Chang
( Director of Cell and Gene Therapy Institute, Korea)
09:15-09:30 Introduction of Cell and Gene therapy institute Yun Sil Chang
(Director of Cell and Gene Therapy Institute, Samsung Medical Center, Korea)
09:30-09:35 Discussion
09:35-10:05 Next Steps for CAR T-cell Therapy in Lymphoma Sattva S Neelapu (The University of Texas MD Anderson Cancer Center, USA)
10:05-10:10 Discussion
10:10-10:40 Piloting pathways for “interventional genomics” in orphan neurologic disease. Timothy Yu (Harvard Medical School, USA)
10:40-10:45 Discussion
10:45-11:00 Retinal gene therapy – Current status and future perspective Sang Jin Kim (Samsung Medical Center, Korea)
11:00-11:05 Discussion
Session II. Advanced disease modeling using Regenerative Medicine Technology Chair : Inho Jo
(Korean Fund for Regenerative Medicine, Korea)
Jihwan Song
(CHA University, Korea)
11:05-11:25 Generation of the human brain organoids to investigate human development and diseases In-Hyun Park
(Yale University School of Medicine, USA)
11:25-11:45 Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment Gabsang Lee
(Johns Hopkins University School of Medicine, USA)
11:45-12:05 Development of biohybrid muscular platforms for regenerative medicine Sung Jin Park
(Georgia Institute of Technology & Emory University School of Medicine, USA)
12:05-12:25 Engineering nano-biomaterials for tissue fabrication and regenerative medicine Su Ryon Shin
(Harvard Medical School, USA)
12:25-12:45 Discussion
12:45-13:35 Lunch
Session III. Perspective: Advanced Technology of Gene Therapy to Clinical Progress Chair: Tae Kwann Park
(Soonchunhyang University Hospital Bucheon, Korea)
Jeehun Lee
(Samsung Medical Center, Korea)
13:35-13:50 Regeneration of articular cartilage, suppression of synovial inflammation, and alleviation of joint pain after intra-articular injection of ICM-203 in canine OA model Dae-Won Kim
(Yonsei University, ICM Co. Ltd.,(CEO), Korea)
13:50-14:05 Brain somatic mutations as RNA therapeutic targets in neurological disorders Jeong Ho Lee
(Korea Advanced Institute of Science and Technology (KAIST), Sovargen Co. LTD., Korea)
14:05-14:15 Discussion
14:15-14:30 Break
Session IV. Perspective: Clinical application of Gene-modified cell therapy Chair : Heechung Kwon
(KIRAMS; President, KSGCT; CEO, Gencellmed Inc., Korea)
Keon Hee Yoo
(Samsung Medical Center, Korea)
14:30-14:45 A method to enhance the safety of Stem Cell-Based Ex-Vivo Therapy Haeyoung Suh-Kim
(Ajou University School of Medicine, CELLeBRAIN(CEO), Korea)
14:45-15:00 CAR T-cell therapy in Samsung Medical Center Seok Jin Kim
(Samsung Medical Center, Korea)
15:00-15:15 Next Generation CAR-T cell therapy against hematological malignancies Kyungho Choi
(Seoul National University College of Medicine, Korea)
14:05-14:15 Discussion
Session V. Recent Advances and Future Perspectives-Organoids Chair : Hyung-Ryong Kim
(Jeonbuk National University, The President of The Organoid Society, Korea)
Jae Ho Kim
(Pusan National University School of Medicine, Korea)
15:30-15:45 p57Kip2 imposes the reserve stem cell state of gastric chief cells Bon-Kyoung Koo
(Center for genome engineering, Institute for Basic Science, Korea)
15:45-16:00 Massive Expansion of hiPSC-derived Cardiomyocytes for Personalized Cardiac Tissue Engineering Soah Lee
(Biopharmaceutical Convergence, School of Pharmacy, Sungkyunkwan University, Korea)
16:00-16:10 Discussion
Session VI. Recent Advances and Future Perspectives-Exosome Chair : Yong Song Gho
(POSTECH, Korea)
Oh Young Bang
(Samsung Medical Center, Korea)
16:10-16:25 Clinical applications of EV DNA for liquid biopsy in lung adenocarcinoma Kye Young Lee
(Precision Medicine Lung Cancer Center, Konkuk University Medical Center, Korea)
16:25-16:40 Exosome engineering for active targeting and intracellular delivery of therapeutic proteins: realization from concept Chulhee Choi
(ILIAS Biologics Inc., KAIST, Korea)
16:40-16:55 Efficient production of stem cell-derived extracellular vesicles with high therapeutic efficacy for the treatment of intractable diseases Ssang-Goo Cho
(Konkuk University & StemEXOne Inc., Korea)
16:55-17:10 Discussion
17:10 ~ Adjourn